Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1344 ARTÍCULOS , VIENDO DEL 1246 AL 1260

Pentraxins and Alzheimer's disease: at the interface between biomarkers and pharmacological targets

Osera C, Pascale A, Amadio M, Venturini L, Govoni S, Ricevuti G.

Ageing Res Rev. 2012 Apr;11(2):189-98. doi: 10.1016/j.arr.2011.12.004. Epub 2011 Dec 15.

Brain serum amyloid P levels are reduced in individuals that lack dementia while having Alzheimer's disease neuropathology

Crawford JR, Bjorklund NL, Taglialatela G, Gomer RH.

Neurochem Res. 2012 Apr;37(4):795-801. doi: 10.1007/s11064-011-0674-0. Epub 2011 Dec 29.

The potential role of microRNA-146 in Alzheimer's disease: biomarker or therapeutic target?

Wang LL, Huang Y, Wang G, Chen SD.

Med Hypotheses. 2012 Mar;78(3):398-401. doi: 10.1016/j.mehy.2011.11.019. Epub 2011 Dec 29.

Molecular neuroimaging in Alzheimer's disease

Matsuda H, Imabayashi E.

Neuroimaging Clin N Am. 2012 Feb;22(1):57-65, viii. doi: 10.1016/j.nic.2011.11.005. Epub 2011 Dec 6.

Lessons from genome-wide association studies findings in Alzheimer's disease

Moraes CF, Lins TC, Carmargos EF, Naves JO, Pereira RW, Nóbrega OT.

Psychogeriatrics. 2012 Mar;12(1):62-73. doi: 10.1111/j.1479-8301.2011.00378.x. Epub 2011 Oct 27.

The effects of APOE-ε4 on the BOLD response

Trachtenberg AJ, Filippini N, Mackay CE.

Neurobiol Aging. 2012 Feb;33(2):323-34. doi: 10.1016/j.neurobiolaging.2010.03.009. Epub 2010 Apr 20.

Loss of serotonin 2A receptors exceeds loss of serotonergic projections in early Alzheimer's disease: a combined [11C]DASB and [18F]altanserin-PET study

Marner L, Frokjaer VG, Kalbitzer J, Lehel S, Madsen K, Baaré WF, Knudsen GM, Hasselbalch SG.

Neurobiol Aging. 2012 Mar;33(3):479-87. doi: 10.1016/j.neurobiolaging.2010.03.023. Epub 2010 May 26.

Association of CLU and PICALM variants with Alzheimer's disease

Kamboh MI, Minster RL, Demirci FY, Ganguli M, Dekosky ST, Lopez OL, Barmada MM.

Neurobiol Aging. 2012 Mar;33(3):518-21. doi: 10.1016/j.neurobiolaging.2010.04.015. Epub 2010 Jun 8.

The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE

Guerreiro RJ, Gustafson DR, Hardy J.

Neurobiol Aging. 2012 Mar;33(3):437-56. doi: 10.1016/j.neurobiolaging.2010.03.025. Epub 2010 Jul 1.

Association and heterogeneity at the GAPDH locus in Alzheimer's disease

Allen M, Cox C, Belbin O, Ma L, Bisceglio GD, Wilcox SL, Howell CC, Hunter TA, Culley O, Walker LP, Carrasquillo MM, Dickson DW, Petersen RC, Graff-Radford NR, Younkin SG, Ertekin-Taner N.

Neurobiol Aging. 2012 Jan;33(1):203.e25-33. doi: 10.1016/j.neurobiolaging.2010.08.002. Epub 2010 Sep 23.

Validation of the neurobehavioral cognitive status examination and the Rivermead Behavioural Memory Test in investigations of dementia

Johansson M, Wressle E.

Scand J Occup Ther. 2012 May;19(3):282-7. doi: 10.3109/11038128.2010.528789. Epub 2010 Nov 25.

Early and late onset Alzheimer's disease patients have distinct patterns of white matter damage

Canu E, Frisoni GB, Agosta F, Pievani M, Bonetti M, Filippi M.

Neurobiol Aging. 2012 Jun;33(6):1023-33. doi: 10.1016/j.neurobiolaging.2010.09.021. Epub 2010 Nov 12.

Diagnostic power of default mode network resting state fMRI in the detection of Alzheimer's disease

Koch W, Teipel S, Mueller S, Benninghoff J, Wagner M, Bokde AL, Hampel H, Coates U, Reiser M, Meindl T.

Neurobiol Aging. 2012 Mar;33(3):466-78. doi: 10.1016/j.neurobiolaging.2010.04.013. Epub 2010 Jun 11.

Contribution of brain imaging to the understanding of gait disorders in Alzheimer's disease: a systematic review

Annweiler C, Beauchet O, Celle S, Roche F, Annweiler T, Allali G, Bartha R, Montero-Odasso M; WALK Team (Working group Angers-London for Knowledge).

Am J Alzheimers Dis Other Demen. 2012 Sep;27(6):371-80. doi: 10.1177/1533317512454710.

Improvement in delusions and hallucinations in patients with dementia with Lewy bodies upon administration of yokukansan, a traditional Japanese medicine

Iwasaki K, Kosaka K, Mori H, Okitsu R, Furukawa K, Manabe Y, Yoshita M, Kanamori A, Ito N, Wada K, Kitayama M, Horiguchi J, Yamaguchi S, Takayama S, Fukuhara R, Ouma S, Nakano S, Hashimoto M, Kinoshita T.

Psychogeriatrics. 2012 Dec;12(4):235-41. doi: 10.1111/j.1479-8301.2012.00413.x.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias